Effects of thalidomide therapy in symptomatic simian immunodeficiency virus-infected cynomolgus monkeys. 1998

S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008252 Macaca fascicularis A species of the genus MACACA which typically lives near the coast in tidal creeks and mangrove swamps primarily on the islands of the Malay peninsula. Burmese Long-Tailed Macaque,Crab-Eating Monkey,Cynomolgus Monkey,M. f. aurea,M. fascicularis,Macaca fascicularis aurea,Monkey, Crab-Eating,Monkey, Cynomolgus,Crab-Eating Macaque,Burmese Long Tailed Macaque,Crab Eating Macaque,Crab Eating Monkey,Crab-Eating Macaques,Crab-Eating Monkeys,Cynomolgus Monkeys,Long-Tailed Macaque, Burmese,Macaque, Burmese Long-Tailed,Macaque, Crab-Eating,Monkey, Crab Eating
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013792 Thalidomide A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action. Sedoval,Thalomid
D015302 Simian Immunodeficiency Virus Species of the genus LENTIVIRUS, subgenus primate immunodeficiency viruses (IMMUNODEFICIENCY VIRUSES, PRIMATE), that induces acquired immunodeficiency syndrome in monkeys and apes (SAIDS). The genetic organization of SIV is virtually identical to HIV. SIV (Simian immunodeficiency virus),Immunodeficiency Viruses, Simian,Simian Immunodeficiency Viruses,Immunodeficiency Virus, Simian
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D018106 CD28 Antigens Costimulatory T-LYMPHOCYTE receptors that have specificity for CD80 ANTIGEN and CD86 ANTIGEN. Activation of this receptor results in increased T-cell proliferation, cytokine production and promotion of T-cell survival. Antigens, CD28,CD28 Antigen,T-Cell-Specific Surface Glycoprotein CD28,TP44 Receptor,Antigen, CD28,Receptor, TP44,T Cell Specific Surface Glycoprotein CD28

Related Publications

S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
December 1990, The American journal of pathology,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
January 1991, Journal of acquired immune deficiency syndromes,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
September 1998, AIDS research and human retroviruses,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
October 1991, Laboratory investigation; a journal of technical methods and pathology,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
December 2001, Virology,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
January 1993, Advances in experimental medicine and biology,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
June 2007, Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
March 1992, AIDS (London, England),
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
February 1999, Neuropathology and applied neurobiology,
S Di Fabio, and D Trabattoni, and A Geraci, and S Ruzzante, and G Panzini, and M L Fusi, and F Chiarotti, and F Corrias, and R Belli, and P Verani, and A Dalgleish, and M Clerici, and F Titti
January 2009, The Journal of infectious diseases,
Copied contents to your clipboard!